Ardelyx, Inc.
Pharmaceutical company · Fremont, California, United States · Nasdaq: ARDX
Ardelyx, Inc. is a pharmaceutical company headquartered in Fremont, California, United States. Its earliest recorded incorporation is in 2007. Its shares trade on Nasdaq under the ticker ARDX. It has reported private securities offerings to the US SEC, most recently $110 million sold in a notice filed in 2016.
Ardelyx at a glance
What does Ardelyx do?
Private fundraising reported to the SEC
4 Form D notices; the most recent reported $110 million sold (2016).
Frequently asked questions about Ardelyx
Where is Ardelyx headquartered?
Ardelyx, Inc. is headquartered in Fremont, California, United States.
What does Ardelyx do?
Ardelyx, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Ardelyx a public company?
Yes. Ardelyx, Inc. trades on Nasdaq under the ticker ARDX.
When was Ardelyx founded?
The earliest incorporation on record for Ardelyx, Inc. is in 2007, according to public company registers.
Similar companies
- Abvc Biopharma, Inc.Fremont, California, United States
- Zosano Pharma CorpFremont, California, United States
- Quark Pharmaceuticals IncFremont, California, United States
- Nova Pneuma Inc.Fremont, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences